HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Jin Wang Selected Research

Vision Disorders (Hemeralopia)

1/2021Referral for disease-related visual impairment using retinal photograph-based deep learning: a proof-of-concept, model development study.
8/2014Adherence to dietary guidelines and the 10-year cumulative incidence of visual impairment: the Blue Mountains Eye Study.
1/2014Visual impairment corrected via cataract surgery and 5-year survival in a prospective cohort.
12/2006Assessment of vision-related quality of life in an older population subsample: The Blue Mountains Eye Study.
10/2006Association between vision and hearing impairments and their combined effects on quality of life.
2/2003Visual impairment and nursing home placement in older Australians: the Blue Mountains Eye Study.
1/2003Five-year change in visual acuity and incidence of visual impairment: the Blue Mountains Eye Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Jin Wang Research Topics

Disease

49Hypertension (High Blood Pressure)
01/2020 - 10/2003
47Macular Degeneration (Age-Related Maculopathy)
10/2020 - 10/2002
45Cataract (Cataracts)
01/2020 - 08/2002
41Diabetic Retinopathy (Retinopathy, Diabetic)
06/2020 - 07/2006
17Stroke (Strokes)
10/2017 - 07/2006
14Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 07/2006
13Myopia
01/2019 - 03/2007
12Obesity
10/2019 - 05/2006
10Atherosclerosis
12/2014 - 07/2006
9Chronic Renal Insufficiency
11/2017 - 01/2006
8Type 2 Diabetes Mellitus (MODY)
11/2018 - 07/2006
8Diabetes Mellitus
11/2015 - 01/2006
8Glaucoma
05/2013 - 12/2002
7Vision Disorders (Hemeralopia)
01/2021 - 01/2003
7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2016 - 01/2009
7Inflammation (Inflammations)
01/2016 - 05/2007
6Eye Diseases (Eye Disease)
01/2021 - 02/2008
6Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2018 - 02/2007
6Retinal Vein Occlusion
11/2013 - 03/2006
5Myocardial Infarction
01/2016 - 07/2006
5Hearing Loss (Hearing Impairment)
07/2014 - 10/2006
5Epiretinal Membrane (Epiretinal Membranes)
08/2013 - 01/2003
5Vascular Diseases (Vascular Disease)
08/2012 - 01/2009
5Coronary Disease (Coronary Heart Disease)
06/2011 - 01/2006
5Birth Weight (Birth Weights)
05/2011 - 11/2007
4Lacunar Stroke
10/2014 - 07/2009
4Geographic Atrophy
02/2013 - 07/2004
3Genetic Predisposition to Disease (Genetic Predisposition)
10/2020 - 03/2014
3Atrophy
01/2018 - 10/2010
3Glucose Intolerance
12/2017 - 08/2006
3Pterygium
06/2013 - 03/2005
3Ischemic Stroke
02/2011 - 12/2009
3Microaneurysm
10/2010 - 06/2007
3Hemorrhage
10/2010 - 06/2007
3Dyslipidemias (Dyslipidemia)
01/2009 - 07/2006
3Embolism (Embolus)
11/2008 - 03/2006
3Ocular Hypertension (Glaucoma, Suspect)
02/2005 - 12/2002
2Refractive Errors (Refractive Error)
12/2017 - 02/2013
2Diabetes Complications
01/2017 - 12/2009
2Low Vision (Subnormal Vision)
03/2014 - 06/2005
2Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2013 - 01/2012
2Cognitive Dysfunction
02/2012 - 10/2009
2Astigmatism
08/2011 - 08/2008
2Hyperopia (Hypermetropia)
08/2011 - 03/2007
2Cerebral Small Vessel Diseases
02/2011 - 07/2009
2Hypercholesterolemia
10/2010 - 03/2006
2Arcus Senilis
10/2010 - 02/2004

Drug/Important Bio-Agent (IBA)

127Retinaldehyde (Retinal)IBA
01/2021 - 10/2002
23Glucose (Dextrose)FDA LinkGeneric
03/2018 - 10/2004
16CholesterolIBA
01/2018 - 02/2004
9Complement Factor H (Factor H)IBA
10/2020 - 04/2008
8LipidsIBA
12/2017 - 07/2007
8Antihypertensive Agents (Antihypertensives)IBA
02/2010 - 10/2003
7C-Reactive ProteinIBA
01/2016 - 10/2008
6HDL CholesterolIBA
11/2017 - 07/2006
6ApolipoproteinsIBA
01/2013 - 07/2006
6Mitochondrial DNA (mtDNA)IBA
01/2009 - 12/2004
5Blood Glucose (Blood Sugar)IBA
01/2020 - 12/2003
5Hemoglobins (Hemoglobin)IBA
01/2020 - 01/2006
5CreatinineIBA
10/2017 - 04/2013
5HomocysteineIBA
05/2016 - 02/2007
5Triglycerides (Triacylglycerol)IBA
03/2015 - 07/2008
5CellophaneIBA
08/2013 - 01/2003
5SteroidsIBA
01/2013 - 10/2008
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2017 - 01/2006
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2015 - 07/2008
4AntioxidantsIBA
03/2014 - 12/2002
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2020 - 06/2007
3Insulin (Novolin)FDA Link
01/2020 - 09/2010
3Proteins (Proteins, Gene)FDA Link
10/2019 - 06/2007
3hydroxide ionIBA
12/2017 - 12/2002
3Folic Acid (Vitamin M)FDA LinkGeneric
11/2014 - 02/2007
3Biomarkers (Surrogate Marker)IBA
05/2014 - 09/2010
3VitaminsIBA
07/2013 - 12/2002
3HDL LipoproteinsIBA
01/2013 - 07/2004
3Biological ProductsIBA
09/2011 - 10/2006
3ZincIBA
06/2008 - 12/2002
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2020 - 06/2004
2P-2 (P 2)IBA
01/2019 - 01/2012
2Indicators and Reagents (Reagents)IBA
01/2017 - 01/2010
2ORALIT (ORS)IBA
05/2016 - 07/2004
2AlbuminsIBA
12/2014 - 01/2012
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
11/2014 - 02/2007
2tyramine-deoxysorbitolIBA
08/2014 - 08/2013
2Fenofibrate (CiL)FDA LinkGeneric
12/2013 - 03/2008
2Pharmaceutical PreparationsIBA
12/2013 - 06/2004
2LDL CholesterolIBA
08/2013 - 10/2010
2Apolipoproteins E (ApoE)IBA
01/2013 - 07/2006
2Apolipoprotein A-I (Apolipoprotein A1)IBA
07/2012 - 02/2011
2Lipoproteins (Lipoprotein)IBA
02/2011 - 01/2009
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2011 - 12/2009
2Fatty Acids (Saturated Fatty Acids)IBA
05/2009 - 07/2006

Therapy/Procedure

13Slit Lamp
07/2013 - 08/2002
8Lasers (Laser)
11/2018 - 12/2009
8Phacoemulsification
03/2014 - 08/2009
3Light Coagulation
11/2018 - 05/2013
3Hearing Aids (Hearing Aid)
07/2014 - 04/2007
3Therapeutics
03/2014 - 11/2011
2Glycemic Control
06/2020 - 01/2019
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
11/2010 - 06/2003